These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 34410989)

  • 21. [A Case of Perforation of the Diverticulum of the Appendix during Chemotherapy with Ramucirumab plus Nab-Paclitaxel for Gastric Cancer].
    Kurihara M; Sawazaki S; Kawabe T; Minowa K; Akimoto N; Tsuchiya K; Kato A; Higuchi A; Rino Y; Matsukawa H; Saeki H
    Gan To Kagaku Ryoho; 2021 Oct; 48(10):1293-1295. PubMed ID: 34657068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
    Meguro E; Kimura T; Noda Y; Matsumoto Y; Irinoda T; Hayakawa Y; Kobayashi M; Takagane A; Hioki J
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):249-52. PubMed ID: 17301537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric cancer with Fanconi anemia in adolescent and young adult patient diagnosed by comprehensive genome profiling using next-generation sequencing.
    Namikawa T; Tanaka T; Utsunomiya M; Yokota K; Munekage M; Maeda H; Kitagawa H; Kurioka Y; Satake H; Kobayashi M; Hanazaki K; Seo S
    Clin J Gastroenterol; 2024 Feb; 17(1):12-17. PubMed ID: 37934348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A Case Report of P0CY1 Gastric Cancer Achieved Long-Term Survival after Treated with Ramucirumab Monotherapy].
    Udagawa M; Adikrisna R; Yamasaki Y; Ito A; Kobayashi K; Enjoji M; Kirimura S
    Gan To Kagaku Ryoho; 2020 Dec; 47(13):2068-2070. PubMed ID: 33468803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A Case Report of Inoperable Gastric Cancer with Peritoneal Dissemination, Liver Metastasis, and Lung Metastasis Successfully Treated with Weekly Paclitaxel and Ramucirumab].
    Takahashi S; Hanaka J; Takahashi M; Goya T
    Gan To Kagaku Ryoho; 2019 Jun; 46(6):1065-1067. PubMed ID: 31273177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report.
    Hidaka Y; Arigami T; Osako Y; Desaki R; Hamanoue M; Takao S; Kirishima M; Ohtsuka T
    World J Surg Oncol; 2022 Jun; 20(1):193. PubMed ID: 35689267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer].
    Kitajima Y; Yakabe T; Ohtsuka T; Tanaka M; Sato S; Nakafusa Y; Miyazaki K
    Gan To Kagaku Ryoho; 2009 May; 36(5):851-4. PubMed ID: 19461193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
    Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
    BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A Case of Advanced Gastric Cancer with Synchronous Liver Metastases Responding to Preoperative Combination Chemotherapy with S-1 plus Oxaliplatin(SOX)].
    Ebisui C; Hamano R; Minoji T; Kitahara T; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Kinuta M; Ohishi K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1263-1265. PubMed ID: 29394601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ramucirumab Beyond Disease Progression After Paclitaxel Plus Ramucirumab in Gastric Cancer: A Phase II Trial.
    Sato Y; Yamashita H; Yagi K; Nomura S; Seto Y
    Anticancer Res; 2024 Jul; 44(7):3125-3131. PubMed ID: 38925825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
    Di Bartolomeo M; Niger M; Morano F; Corallo S; Antista M; Tamberi S; Lonardi S; Di Donato S; Berardi R; Scartozzi M; Cardellino GG; Di Costanzo F; Rimassa L; Luporini AG; Longarini R; Zaniboni A; Bertolini A; Tomasello G; Pinotti G; Scagliotti G; Tortora G; Bonetti A; Spallanzani A; Frassineti GL; Tassinari D; Giuliani F; Cinieri S; Maiello E; Verusio C; Bracarda S; Catalano V; Basso M; Ciuffreda L; De Vita F; Parra HS; Fornaro L; Caporale M; de Braud F; Pietrantonio F
    BMC Cancer; 2019 Mar; 19(1):283. PubMed ID: 30922323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine Carcinoma of the Stomach: A Response to Combination Chemotherapy Consisting of Ramucirumab Plus Paclitaxel.
    Matsubara Y; Ando T; Hosokawa A; Mihara H; Takagi H; Nakata N; Yoshita H; Nanjo S; Kajiura S; Fujinami H; Sugiyama T
    Intern Med; 2018 Mar; 57(5):671-675. PubMed ID: 29151523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of multiple hepatic metastases of gastric cancer that showed complete regression by systemic chemotherapy using paclitaxel and UFT-E].
    Okamura H; Fujiwara H; Ichikawa D; Okamoto K; Kikuchi S; Kubota T; Ikoma H; Nakanishi M; Ochiai T; Sakakura C; Kokuba Y; Taniguchi H; Sonoyama T; Otsuji E
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):987-90. PubMed ID: 19542721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.
    Ishikawa M; Iwasa S; Nagashima K; Aoki M; Imazeki H; Hirano H; Shoji H; Honma Y; Okita N; Takashima A; Kato K; Saruta M; Boku N
    Invest New Drugs; 2020 Apr; 38(2):533-540. PubMed ID: 31264067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A Case of Advanced Gastric Cancer with Long-Term Survival Due to Successful Ramucirumab and Paclitaxel Therapy].
    Ono Y; Aoyama T; Morita J; Maezawa Y; Amano S; Sawazaki S; Numata M; Tamagawa H; Sato T; Oshima T; Yoshikawa T; Ozawa Y; Yukawa N; Masuda M; Rino Y
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2156-2158. PubMed ID: 30692316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemotherapy and Conversion Surgery for Advanced Gastric Cancer Patient with a Liver Metastasis in 81 Years Old Woman].
    Kawashima Y; Ehara K; Kawakami H; Asakura T; Kumekawa Y; Kanda H
    Gan To Kagaku Ryoho; 2024 Feb; 51(2):202-204. PubMed ID: 38449413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
    Wilke H; Muro K; Van Cutsem E; Oh SC; Bodoky G; Shimada Y; Hironaka S; Sugimoto N; Lipatov O; Kim TY; Cunningham D; Rougier P; Komatsu Y; Ajani J; Emig M; Carlesi R; Ferry D; Chandrawansa K; Schwartz JD; Ohtsu A;
    Lancet Oncol; 2014 Oct; 15(11):1224-35. PubMed ID: 25240821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of unresectable HER2-positive advanced gastric cancer successfully treated by combination therapy with trastuzumab and paclitaxel].
    Ojima E; Nishimura G; Nishijima K; Futagami F; Nakamura T; Hosokawa A
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2339-41. PubMed ID: 23268070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A Case of Recurrent Gastric Cancer with Grade 3 Proteinuria Caused by Ramucirumab plus Paclitaxel Therapy].
    Kimura Y; Makari Y; Mikami J; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Fujita J; Furukawa H; Yasuda T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1080-1082. PubMed ID: 29394540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of HER2-positive gastric cancer successfully treated with trastuzumab plus capecitabine plus cisplatin chemotherapy as third-line treatment].
    Murata Y; Matsuura T; Kanoshima K; Kuwabara H; Fuyuki A; Tomeno W; Taniguchi R; Uchiyama T; Kuriyama H; Hata Y
    Gan To Kagaku Ryoho; 2013 Jul; 40(7):933-6. PubMed ID: 23863740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.